Northern Trust Corp Infla Rx N.V. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Infla Rx N.V. stock. As of the latest transaction made, Northern Trust Corp holds 666,845 shares of IFRX stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
666,845
Previous 32,800
1933.06%
Holding current value
$1.33 Million
Previous $50,000
3220.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IFRX
# of Institutions
34Shares Held
12.9MCall Options Held
19.3KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY5.73MShares$11.5 Million0.59% of portfolio
-
683 Capital Management, LLC New York, NY2.07MShares$4.14 Million0.37% of portfolio
-
Morgan Stanley New York, NY2.04MShares$4.08 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL638KShares$1.28 Million0.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL626KShares$1.25 Million0.1% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $88.4M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...